Literature DB >> 5707788

Pituitary dwarfism with high serum levels of growth hormone.

Z Laron, A Pertzelan, M Karp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5707788

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN： 0021-2180


× No keyword cloud information.
  33 in total

1.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 2.  Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

3.  Long-lived crowded-litter mice exhibit lasting effects on insulin sensitivity and energy homeostasis.

Authors:  Marianna Sadagurski; Taylor Landeryou; Manuel Blandino-Rosano; Gillian Cady; Lynda Elghazi; Daniel Meister; Lauren See; Andrzej Bartke; Ernesto Bernal-Mizrachi; Richard A Miller
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

4.  Identification of two novel mutations in the human growth hormone receptor gene.

Authors:  O Shevah; P Borrelli; M Rubinstein; Z Laron
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

5.  Radiographic abnormalities in Laron dwarfism.

Authors:  M Vasil; A Baxova; K Kozlowski
Journal:  Pediatr Radiol       Date:  1994

Review 6.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

7.  The ontogenesis of human fetal hormones. I. Growth hormone and insulin.

Authors:  S L Kaplan; M M Grumbach; T H Shepard
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

8.  Pseudopituitary dwarfism due to resistance to somatomedin: a new syndrome.

Authors:  J R Bierich; H Moeller; M B Ranke; R G Rosenfeld
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

9.  Renal function in Laron syndrome patients treated by insulin-like growth factor-I.

Authors:  B Klinger; Z Laron
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

10.  Puberty in Laron type dwarfism.

Authors:  Z Laron; R Sarel; A Pertzelan
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.